J&J CFO Caruso on 2Q Results, Product Pipeline, M&A

The video discusses Johnson & Johnson's strong Q2 results, highlighting growth in pharmaceuticals, consumer products, and medical devices. Key topics include the pharmaceutical pipeline, competition, the strategic acquisition of Vogue, and the impact of Brexit. The restructuring of the medical devices segment is also covered, along with the company's approach to mergers and acquisitions and financial strategies in light of currency fluctuations.

How does Johnson & Johnson view the competition for their product Remicade?

What challenges does Johnson & Johnson anticipate from Brexit?

What is Johnson & Johnson's strategy regarding mergers and acquisitions?